AU2002214324A1 - Medicinal compositions - Google Patents
Medicinal compositionsInfo
- Publication number
- AU2002214324A1 AU2002214324A1 AU2002214324A AU2002214324A AU2002214324A1 AU 2002214324 A1 AU2002214324 A1 AU 2002214324A1 AU 2002214324 A AU2002214324 A AU 2002214324A AU 2002214324 A AU2002214324 A AU 2002214324A AU 2002214324 A1 AU2002214324 A1 AU 2002214324A1
- Authority
- AU
- Australia
- Prior art keywords
- medicinal compositions
- medicinal
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000354327 | 2000-11-21 | ||
| JP2000-354327 | 2000-11-21 | ||
| JP2001164009 | 2001-05-31 | ||
| JP2001-164009 | 2001-05-31 | ||
| PCT/JP2001/010095 WO2002041890A1 (en) | 2000-11-21 | 2001-11-19 | Medicinal compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002214324A1 true AU2002214324A1 (en) | 2002-08-08 |
| AU2002214324B2 AU2002214324B2 (en) | 2004-07-29 |
Family
ID=26604360
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002214324A Expired AU2002214324B2 (en) | 2000-11-21 | 2001-11-19 | Medicinal compositions |
| AU1432402A Pending AU1432402A (en) | 2000-11-21 | 2001-11-19 | Medicinal compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU1432402A Pending AU1432402A (en) | 2000-11-21 | 2001-11-19 | Medicinal compositions |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US6878703B2 (en) |
| EP (2) | EP1595540A1 (en) |
| KR (1) | KR100656716B1 (en) |
| CN (1) | CN1265788C (en) |
| AT (1) | ATE324890T1 (en) |
| AU (2) | AU2002214324B2 (en) |
| BR (1) | BR0115516A (en) |
| CA (1) | CA2429260A1 (en) |
| CY (1) | CY1106134T1 (en) |
| CZ (1) | CZ20031367A3 (en) |
| DE (1) | DE60119368T2 (en) |
| DK (1) | DK1336407T3 (en) |
| ES (1) | ES2262689T3 (en) |
| HK (1) | HK1054692A1 (en) |
| HU (1) | HUP0400553A3 (en) |
| IL (2) | IL155965A0 (en) |
| MX (1) | MXPA03004463A (en) |
| NO (1) | NO332938B1 (en) |
| NZ (1) | NZ525913A (en) |
| PL (1) | PL207252B1 (en) |
| PT (1) | PT1336407E (en) |
| SK (1) | SK5992003A3 (en) |
| TW (1) | TWI262076B (en) |
| WO (1) | WO2002041890A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004208615C1 (en) * | 2003-01-31 | 2010-05-13 | Daiichi Sankyo Company, Limited | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
| AU2004270161A1 (en) | 2003-08-28 | 2005-03-17 | Nicox S.A. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| CN1993355A (en) * | 2004-09-02 | 2007-07-04 | 特瓦制药工业有限公司 | Purification of olmesartan medoxomil |
| US20060074117A1 (en) * | 2004-09-02 | 2006-04-06 | Lilach Hedvati | Purification of olmesartan medoxomil |
| US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
| WO2006091716A2 (en) | 2005-02-24 | 2006-08-31 | Nitromed, Inc. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
| WO2006123765A1 (en) * | 2005-05-20 | 2006-11-23 | Daiichi Sankyo Company, Limited | Film coated preparation |
| TWI367756B (en) * | 2005-05-20 | 2012-07-11 | Sankyo Co | A film-coated drug product comprising dextrose |
| WO2007047838A2 (en) * | 2005-10-20 | 2007-04-26 | Dr. Reddy's Laboratories Ltd. | Process for preparing olmesartan medoxomil |
| US8077769B2 (en) * | 2006-03-28 | 2011-12-13 | Sony Corporation | Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach |
| SI1891952T1 (en) * | 2006-05-04 | 2012-02-29 | Lek Pharmaceuticals, D.D. | Pharmaceutical composition of olmesartan medoxomil |
| CN101534798B (en) * | 2006-10-30 | 2012-02-15 | 韩诺生物制约株式会社 | Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockers |
| JP5554699B2 (en) | 2008-03-13 | 2014-07-23 | 第一三共株式会社 | Improving dissolution properties of formulations containing olmesartan medoxomil |
| US20100008956A1 (en) * | 2008-07-08 | 2010-01-14 | Jie Du | Composition and combinations of carboxylic acid losartan in dosage forms |
| DE102008059206A1 (en) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic |
| WO2010075347A2 (en) | 2008-12-23 | 2010-07-01 | Takeda Pharmaceutical Company Limited | Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone |
| IT1400311B1 (en) | 2010-05-10 | 2013-05-24 | Menarini Int Operations Lu Sa | ASSOCIATION OF INHIBITORS OF XANTHIN OXIDASE AND ANTAGONISTS OF THE Angiotensin II RECEPTOR AND THEIR USE. |
| CN112567469B (en) | 2018-06-14 | 2023-11-07 | 阿斯利康(英国)有限公司 | Method for treating hypertension with pharmaceutical compositions of angiotensin II receptor blockers |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3025292A (en) | 1962-03-13 | Reduction of i | ||
| US3009911A (en) | 1961-11-21 | Derivatives of j | ||
| US2783241A (en) | 1957-02-26 | S-acylimino-x-substituted-az-i | ||
| US2976289A (en) | 1961-03-21 | X-tetrahydro - | ||
| US3254076A (en) | 1966-05-31 | Sulfamyl hydro | ||
| US3108097A (en) | 1963-10-22 | Ehnojs | ||
| US2554816A (en) | 1950-04-04 | 1951-05-29 | American Cyanamid Co | Heterocyclic sulfonamides and methods of preparation thereof |
| GB795174A (en) | 1954-10-13 | 1958-05-21 | Upjohn Co | Heterocyclic sulphonamides |
| US2835702A (en) | 1956-05-02 | 1958-05-20 | Merck & Co Inc | Benzene 1, 3 disulfonamides possessing diuretic properties |
| US2980679A (en) | 1957-04-04 | 1961-04-18 | Omikron Gagliardi Societa Di F | Process for preparing heterocyclic sulfonamides |
| US3055904A (en) | 1957-11-04 | 1962-09-25 | Geigy Chem Corp | New isoindoline derivatives |
| GB851287A (en) | 1958-07-10 | 1960-10-12 | British Drug Houses Ltd | 5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof |
| US3058882A (en) | 1959-12-28 | 1962-10-16 | Hoechst Ag | N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof |
| US3255241A (en) | 1961-01-19 | 1966-06-07 | Merck & Co Inc | (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids |
| GB979994A (en) | 1961-07-28 | 1965-01-06 | May & Baker Ltd | Isoindolinone derivatives |
| US3265573A (en) | 1962-07-27 | 1966-08-09 | Squibb & Sons Inc | Benzothiadiazinesulfonamide-1, 1-dioxide composition |
| BE639386A (en) | 1962-10-30 | |||
| DE1278443C2 (en) | 1963-11-30 | 1975-07-24 | Bayer Ag, 5090 Leverkusen | PROCESS FOR THE PREPARATION OF 2,4-DISULFONAMIDE-1-CHLOROBENZENE |
| US3163645A (en) | 1964-09-25 | 1964-12-29 | Ciba Geigy Corp | Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides |
| DE1270544B (en) | 1965-06-19 | 1968-06-20 | Beiersdorf Ag | 4-chloro-5-sulfamylsalicylic acid (2 ', 6'-dimethyl) anilide and its alkali or ammonium salts and processes for their preparation |
| US3360518A (en) | 1966-01-03 | 1967-12-26 | Wallace & Tiernan Inc | Tetrahydro-halo-sulfamyl quinazolinones |
| US3634583A (en) | 1969-07-24 | 1972-01-11 | Leo Pharm Prod Ltd | Pharmaceutical composition for the treatment of oedematous conditions and hypertension |
| BE757001A (en) | 1969-10-10 | 1971-03-16 | Cerpha | HETEROCYCLIC DERIVATIVES OF PHENOXY ACETIC ACIDS AND THEIR PREPARATION |
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| EP0733366B1 (en) * | 1988-01-07 | 1998-04-01 | E.I. Du Pont De Nemours And Company | Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics |
| EP0400835A1 (en) * | 1989-05-15 | 1990-12-05 | Merck & Co. Inc. | Substituted benzimidazoles as angiotensin II antagonists |
| US5656650A (en) * | 1990-12-14 | 1997-08-12 | Smithkline Beecham Corp. | Angiotensin II receptor blocking compositions |
| CA2229000C (en) * | 1991-02-21 | 2002-04-09 | Sankyo Company, Limited | 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| US5310928A (en) | 1991-11-18 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Process for preparing biphenyltetrazole compounds |
| US5264447A (en) * | 1992-09-01 | 1993-11-23 | Merck & Co., Inc. | Angiotensin II antagonist |
-
2001
- 2001-11-19 AT AT01982846T patent/ATE324890T1/en active
- 2001-11-19 PL PL361093A patent/PL207252B1/en unknown
- 2001-11-19 HU HU0400553A patent/HUP0400553A3/en unknown
- 2001-11-19 DK DK01982846T patent/DK1336407T3/en active
- 2001-11-19 CN CNB018221130A patent/CN1265788C/en not_active Expired - Lifetime
- 2001-11-19 CZ CZ20031367A patent/CZ20031367A3/en unknown
- 2001-11-19 EP EP05008297A patent/EP1595540A1/en not_active Withdrawn
- 2001-11-19 NZ NZ525913A patent/NZ525913A/en not_active IP Right Cessation
- 2001-11-19 CA CA002429260A patent/CA2429260A1/en not_active Abandoned
- 2001-11-19 AU AU2002214324A patent/AU2002214324B2/en not_active Expired
- 2001-11-19 SK SK599-2003A patent/SK5992003A3/en not_active Application Discontinuation
- 2001-11-19 AU AU1432402A patent/AU1432402A/en active Pending
- 2001-11-19 ES ES01982846T patent/ES2262689T3/en not_active Expired - Lifetime
- 2001-11-19 BR BR0115516-4A patent/BR0115516A/en not_active Application Discontinuation
- 2001-11-19 EP EP01982846A patent/EP1336407B1/en not_active Revoked
- 2001-11-19 KR KR1020037006752A patent/KR100656716B1/en active IP Right Review Request
- 2001-11-19 PT PT01982846T patent/PT1336407E/en unknown
- 2001-11-19 DE DE60119368T patent/DE60119368T2/en not_active Expired - Lifetime
- 2001-11-19 IL IL15596501A patent/IL155965A0/en unknown
- 2001-11-19 MX MXPA03004463A patent/MXPA03004463A/en active IP Right Grant
- 2001-11-19 WO PCT/JP2001/010095 patent/WO2002041890A1/en active IP Right Grant
- 2001-11-21 TW TW090128798A patent/TWI262076B/en not_active IP Right Cessation
-
2003
- 2003-05-18 IL IL155965A patent/IL155965A/en unknown
- 2003-05-20 US US10/442,874 patent/US6878703B2/en not_active Expired - Fee Related
- 2003-05-20 NO NO20032261A patent/NO332938B1/en not_active IP Right Cessation
- 2003-09-29 HK HK03107005A patent/HK1054692A1/en not_active IP Right Cessation
-
2004
- 2004-12-23 US US11/020,624 patent/US20050113367A1/en not_active Abandoned
-
2006
- 2006-07-31 CY CY20061101069T patent/CY1106134T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU781269C (en) | Pharmaceutical compositions | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AU2002313236A1 (en) | Medicinal compositions | |
| AU3192700A (en) | Medicinal compositions | |
| AU6219601A (en) | Pharmaceutical compositions | |
| AU2005300A (en) | Medicinal compositions | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2002258221A1 (en) | Medicinal composition | |
| AUPQ875700A0 (en) | Combination compositions | |
| AU8576801A (en) | Pharmaceutical compositions | |
| HUP0400553A3 (en) | Pharmaceutical compositions | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
| AU1390002A (en) | Pharmaceutical compositions | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU2002210433A1 (en) | Dental compositions | |
| AU2001270235A1 (en) | Oral compositions | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2001235764A1 (en) | Compositions | |
| AU2001290669A1 (en) | Oral compositions | |
| AU2001223721A1 (en) | Dental compositions | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU3586401A (en) | Pharmaceutical composition |